A Multicenter Pediatric Deep Brain Stimulation Registry
NCT06585618
Anxiety Disorders, Basal Ganglia Diseases
Boston, Massachusetts, United States
View Trial DetailsNCT Number: NCT04287166
Cerebral Palsy (CP) is the most common motor dysfunction in childhood. Traditionally, diagnosis is set between 12 and 24 months of age. This study will evaluate feasibility of a new screening procedure for early detection of CP in high-risk infants and investigate how such a procedure can be implemented in the Central Norwegian Regional Health Authority (CNRHA).
The most accurate method to detect and predict CP at an early age is the General Movement Assessment (GMA). GMA is based upon expert observations of infant spontaneous movements in a video. In Central-Norway such expertise is today only present at St. Olavs Hospital, Trondheim University Hospital. Video recordings by health personnel and parents will be used in follow-up programs within CNRHA for remote expert based GMA. In addition, machine learning models will be applied for automatic detection of CP.
Early identification of CP will lead to improved function and increased possibility to direct health care resources to the patients who need it most, independent of geographical and expert based constraints.
This study is active but is not currently recruiting participants.
Notify Me0 month–2 month
All sexes
Observational
Department of Pediatrics, Nord-Trøndelag Hospital Trust, Levanger, Norway
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 1 week
Time frame: 1 week
Time frame: 2 years
Time frame: 5 years
St. Olavs Hospital
Other
Feasibility of Remote Early At-risk Diagnosis for Cerebral Palsy in High-risk Infant Follow-up Clinics in The Central Norway Regional Health Authority
Acronym: In-Motion
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06585618
Anxiety Disorders, Basal Ganglia Diseases
Boston, Massachusetts, United States
View Trial DetailsNCT06537622
Brain Damage, Chronic, Brain Diseases
Montreal, Quebec, Canada
View Trial DetailsNCT06658275
Brain Damage, Chronic, Brain Diseases
View Trial DetailsNCT05217186
Brain Damage, Chronic, Brain Diseases
Kahramanmaraş, Dulkadiroglu, Turkey (Türkiye)
View Trial Details